Susquehanna International Group
UTHR icon

Susquehanna International Group’s United Therapeutics UTHR Stock Holding History

Susquehanna International Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$282M Buy
476,000
+293,500
+161% +$146M 0.03% 406
2025
Q4 		$88.9M Sell
182,500
-641,800
-78% -$299M 0.01% 959
2025
Q3 		$346M Buy
824,300
+652,100
+379% +$219M 0.04% 367
2025
Q2 		$49.5M Buy
172,200
+146,900
+581% +$43.9M 0.01% 1181
2025
Q1 		$7.8M Sell
25,300
-3,900
-13% -$1.34M ﹤0.01% 2867
2024
Q4 		$10.3M Sell
29,200
-127,200
-81% -$46.8M ﹤0.01% 2623
2024
Q3 		$56M Buy
156,400
+40,400
+35% +$13.6M 0.01% 1006
2024
Q2 		$37M Buy
116,000
+15,100
+15% +$4M 0.01% 1202
2024
Q1 		$23.2M Buy
100,900
+67,300
+200% +$15.2M ﹤0.01% 1636
2023
Q4 		$7.39M Sell
33,600
-26,500
-44% -$6.11M ﹤0.01% 3070
2023
Q3 		$13.6M Buy
60,100
+17,400
+41% +$4.01M ﹤0.01% 2187
2023
Q2 		$9.43M Sell
42,700
-17,900
-30% -$3.96M ﹤0.01% 2575
2023
Q1 		$13.6M Buy
60,600
+18,200
+43% +$4.49M ﹤0.01% 2105
2022
Q4 		$11.8M Sell
42,400
-13,300
-24% -$3.36M ﹤0.01% 2063
2022
Q3 		$11.7M Buy
55,700
+600
+1% +$134K ﹤0.01% 1967
2022
Q2 		$13M Buy
55,100
+35,200
+177% +$7.16M ﹤0.01% 1875
2022
Q1 		$3.57M Sell
19,900
-9,900
-33% -$1.89M ﹤0.01% 4294
2021
Q4 		$6.44M Sell
29,800
-84,400
-74% -$16.6M ﹤0.01% 3332
2021
Q3 		$21.1M Buy
114,200
+99,800
+693% +$19.7M ﹤0.01% 1919
2021
Q2 		$2.58M Sell
14,400
-60,600
-81% -$11.5M ﹤0.01% 5351
2021
Q1 		$12.5M Buy
75,000
+63,900
+576% +$10.7M ﹤0.01% 2437
2020
Q4 		$1.69M Buy
11,100
+6,600
+147% +$866K ﹤0.01% 5473
2020
Q3 		$455K Sell
4,500
-11,600
-72% -$1.27M ﹤0.01% 7870
2020
Q2 		$1.95M Buy
16,100
+8,100
+101% +$911K ﹤0.01% 4551
2020
Q1 		$759K Sell
8,000
-29,700
-79% -$2.82M ﹤0.01% 6005
2019
Q4 		$3.32M Sell
37,700
-28,500
-43% -$2.51M ﹤0.01% 3536
2019
Q3 		$5.28M Buy
66,200
+16,300
+33% +$1.31M ﹤0.01% 2652
2019
Q2 		$3.9M Buy
49,900
+3,800
+8% +$355K ﹤0.01% 3066
2019
Q1 		$5.41M Buy
46,100
+30,400
+194% +$3.54M ﹤0.01% 2357
2018
Q4 		$1.71M Sell
15,700
-56,200
-78% -$6.52M ﹤0.01% 3766
2018
Q3 		$9.2M Sell
71,900
-38,300
-35% -$4.74M ﹤0.01% 2021
2018
Q2 		$12.5M Buy
110,200
+41,300
+60% +$4.54M ﹤0.01% 1712
2018
Q1 		$7.74M Sell
68,900
-4,500
-6% -$572K ﹤0.01% 2049
2017
Q4 		$10.9M Buy
73,400
+6,600
+10% +$839K ﹤0.01% 1751
2017
Q3 		$7.83M Sell
66,800
-46,600
-41% -$5.95M ﹤0.01% 2005
2017
Q2 		$14.7M Buy
113,400
+55,600
+96% +$6.94M 0.01% 1383
2017
Q1 		$7.83M Sell
57,800
-19,600
-25% -$2.97M ﹤0.01% 1873
2016
Q4 		$11.1M Sell
77,400
-23,600
-23% -$3.01M 0.01% 1458
2016
Q3 		$11.9M Sell
101,000
-18,100
-15% -$2.17M 0.01% 1386
2016
Q2 		$12.6M Sell
119,100
-48,900
-29% -$5.45M 0.01% 1267
2016
Q1 		$18.7M Buy
168,000
+106,000
+171% +$13.4M 0.01% 1040
2015
Q4 		$9.71M Sell
62,000
-42,600
-41% -$6.2M ﹤0.01% 1785
2015
Q3 		$13.7M Buy
104,600
+26,900
+35% +$4.31M 0.01% 1532
2015
Q2 		$13.5M Sell
77,700
-58,200
-43% -$10.5M 0.01% 1679
2015
Q1 		$23.4M Sell
135,900
-67,100
-33% -$10.2M 0.01% 1123
2014
Q4 		$26.3M Sell
203,000
-97,100
-32% -$12.5M 0.01% 1134
2014
Q3 		$38.6M Buy
300,100
+34,900
+13% +$3.6M 0.01% 887
2014
Q2 		$23.5M Buy
265,200
+188,300
+245% +$18.1M 0.01% 1259
2014
Q1 		$7.23M Sell
76,900
-25,700
-25% -$2.63M ﹤0.01% 2395
2013
Q4 		$11.6M Buy
102,600
+54,800
+115% +$4.94M 0.01% 1890
2013
Q3 		$3.77M Sell
47,800
-39,400
-45% -$2.88M ﹤0.01% 3124
2013
Q2 		$5.74M Buy
+87,200
New +$5.62M ﹤0.01% 2442

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Susquehanna International Group's UTHR Position: Q1 2026 in Review

Susquehanna International Group increased its United Therapeutics (UTHR) stake by 117% in Q1 2026, buying an estimated $7.97M and bringing the position to 29,696 shares worth $17.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2387.

Susquehanna International Group first reported a position in UTHR in Q2 2013 and has held it in 41 quarters since. The position peaked at $74M in Q3 2025. 851 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Susquehanna International Group held 29,696 shares of United Therapeutics worth $17.6M as of Q1 2026.
  • Susquehanna International Group bought 16,004 United Therapeutics shares in Q1 2026, an estimated $7.97M.
  • United Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #2387 holding.
  • Susquehanna International Group first reported a position in United Therapeutics in Q2 2013 and has held it in 41 quarters since.
  • Susquehanna International Group's United Therapeutics position peaked at $74M in Q3 2025.
  • 851 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.